Mediaco Holding Inc. (MDIA): Nasdaq/NYSE listing notice — MediaCo receives Nasdaq deficiency notice for bid price below $1.00

Mediaco Holding Inc.

Received deficiency letter on Dec 19, 2025 for closing bid price below $1.00 for 30 consecutive business days.
Common stock remains listed on Nasdaq Capital Market under MDIA; 180-day cure period until June 17, 2026.
To regain compliance, bid price must close at $1.00 or more for at least 10 consecutive business days before deadline.
If not cured by June 17, 2026, may be eligible for second 180-day compliance period if other standards are met.
Company may consider reverse stock split to address deficiency; no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Mediaco Holding Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

December 19, 2025, MediaCo Holding Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock, a

View on SEC.gov

Browse all listing & compliance notices →

Mediaco Holding Inc. filing history →

Source: SEC EDGAR

accession 0001784254-25-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.